文献速递脊柱关节炎

银屑病关节炎疾病活动度测量:PASDAS在严密监测队列中的实施揭示残留疾病负担

Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究为横断面研究,在855例已严密监测的银屑病关节炎(PsA)患者中实施银屑病关节炎疾病活动度评分(PASDAS),以DAS28为锚。基于PASDAS,53.1%患者处于极低/低疾病活动度(VLDA/LDA);而基于DAS28,77.5%患者处于VLDA/LDA。仅达到DAS28 VLDA/LDA但未达到PASDAS VLDA/LDA的患者(25.5%)在肿胀/压痛关节数、患者整体VAS、功能及炎性背痛等指标上显著更差,提示PASDAS可揭示残留疾病活动。

要点

  • 在严密监测队列中,PASDAS识别出约四分之一DAS28判定为VLDA/LDA的患者存在残留疾病活动。
  • 基于PASDAS,53.1%患者处于VLDA/LDA;基于DAS28,77.5%患者处于VLDA/LDA。
  • 仅DAS28 VLDA/LDA而PASDAS未达标的患者,在关节计数、患者整体VAS、功能和炎性背痛等方面显著更差。

核心结论

  • PASDAS实施揭示了先前被DAS28评估为VLDA/LDA的患者中约四分之一存在相关残留疾病活动,强调PASDAS在PsA临床护理中的潜在价值。

研究设计与样本

  • 横断面研究,评估855例PsA患者实施PASDAS后首次访视的数据,该队列已严密监测并以DAS28作为锚。

主要发现

  • 基于PASDAS,53.1%患者处于VLDA/LDA;29.5%患者有≥1个肿胀关节,20.6%有≥1个附着点炎指数点,3.0%有活动性指趾炎。
  • 基于DAS28,77.5%患者处于VLDA/LDA。
  • 同时达到DAS28和PASDAS VLDA/LDA的患者为445例(52.0%),仅达到DAS28 VLDA/LDA的患者为218例(25.5%)。
  • 仅达到DAS28 VLDA/LDA的患者在PASDAS/DAS28计算所用的肿胀和压痛关节数、患者整体疾病活动VAS等参数上显著更差,在其他疾病指标(如功能和炎性背痛)上也显著更差;使用更严格的DAS28 VLDA cutoff时该结果仍存在。

关键数值与推荐

  • PASDAS疾病活动度状态采用既定cutoff分为极低(VLDA)、低(LDA)、中(MDA)和高疾病活动度(HDA)。
  • DAS28作为锚,其VLDA/LDA状态用于与PASDAS VLDA/LDA状态比较。

临床怎么用

  • 在PsA临床护理中,对DAS28判定为VLDA/LDA的患者可考虑使用PASDAS进一步评估,以识别残留疾病活动。

局限性

  • 本研究为横断面研究,仅评估首次访视数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to investigate the disease activity and overall disease burden of (subgroups of) patients with PsA using the Psoriatic Arthritis Disease Activity Score (PASDAS) in an already tightly monitored cohort. METHODS: This is a cross-sectional study evaluating data from the first visit of 855 PsA patients after implementation of the PASDAS in our tightly monitored cohort [e.g. DAS 28 (DAS28) was provided as an anchor]. Differences in clinical outcomes between subgroups of patients using established cut-offs for disease activity status [i.e. very low (VLDA), low (LDA), moderate (MDA), and high disease activity (HDA)] were examined. RESULTS: Based on the PASDAS, 53.1% of patients were in VLDA/LDA. 29.5% of patients had ≥1 swollen joint, 20.6% had ≥1 enthesitis index point and 3.0% had active dactylitis. Based on DAS28, 77.5% of the patients were in VLDA/LDA. Patients reaching both DAS28 VLDA/LDA status and PASDAS VLDA/LDA status [N = 445 (52.0%)] were compared with patients reaching only DAS28 VLDA/LDA status [N = 218 (25.5%)]. For these latter patients, significantly worse scores on separate parameters were found in measures used for PASDAS/DAS28 calculation (e.g. swollen and tender joint count and patient's visual analogue scale global disease activity) as well as other disease measures (e.g. function and inflammatory back pain). This result remained, even when the stricter VLDA cut-off was used for the DAS28. CONCLUSION: PASDAS implementation uncovered relevant residual disease activity in a quarter of patients previously assessed as being in DAS28 VLDA/LDA, underscoring the potential value of PASDAS measurements in PsA clinical care.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Mulder MLM, van Hal TW, van den Hoogen FHJ, et al. Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden. Rheumatology (Oxford). 2021. PMID: 33331947. doi:10.1093/rheumatology/keaa766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。